Income Tax Expense (Benefit) in USD of CHEMED CORP from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
CHEMED CORP quarterly/annual Income Tax Expense (Benefit) history and change rate from Q1 2010 to Q3 2025.
  • CHEMED CORP Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $19.3M, a 23.5% decline year-over-year.
  • CHEMED CORP Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $91.7M, a 1.67% decline year-over-year.
  • CHEMED CORP annual Income Tax Expense (Benefit) for 2024 was $97.5M, a 25.2% increase from 2023.
  • CHEMED CORP annual Income Tax Expense (Benefit) for 2023 was $77.9M, a 2.74% decline from 2022.
  • CHEMED CORP annual Income Tax Expense (Benefit) for 2022 was $80.1M, a 2.09% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

CHEMED CORP Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $91.7M $19.3M -$5.95M -23.5% 01 Jul 2025 30 Sep 2025 10-Q 31 Oct 2025
Q2 2025 $97.6M $18.6M -$4.32M -18.8% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $102M $23.9M +$4.45M +22.9% 01 Jan 2025 31 Mar 2025 10-Q 28 Apr 2025
Q4 2024 $97.5M $29.8M +$4.26M +16.7% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 $93.2M $25.3M +$6.95M +37.9% 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2025
Q2 2024 $86.3M $22.9M +$5.97M +35.2% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025
Q1 2024 $80.3M $19.5M +$2.42M +14.2% 01 Jan 2024 31 Mar 2024 10-Q 28 Apr 2025
Q4 2023 $77.9M $25.5M +$5.27M +26% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $72.6M $18.3M -$1.29M -6.59% 01 Jul 2023 30 Sep 2023 10-Q 01 Nov 2024
Q2 2023 $73.9M $17M -$2.68M -13.7% 01 Apr 2023 30 Jun 2023 10-Q 26 Jul 2024
Q1 2023 $76.6M $17M -$3.49M -17% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024
Q4 2022 $80.1M $20.3M -$1.23M -5.71% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025
Q3 2022 $81.3M $19.6M -$3.82M -16.3% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023
Q2 2022 $85.1M $19.7M +$1.07M +5.74% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023
Q1 2022 $84M $20.5M +$2.27M +12.4% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023
Q4 2021 $81.8M $21.5M -$10.6M -33% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024
Q3 2021 $92.4M $23.4M +$9.54M +68.7% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $82.8M $18.6M +$1.06M +6.06% 01 Apr 2021 30 Jun 2021 10-Q 29 Jul 2022
Q1 2021 $81.8M $18.3M +$5.23M +40.1% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022
Q4 2020 $76.5M $32.1M +$18.1M +129% 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023
Q3 2020 $58.5M $13.9M +$5.91M +74% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021
Q2 2020 $52.5M $17.5M +$3.95M +29.1% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021
Q1 2020 $48.6M $13M +$6.91M +113% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021
Q4 2019 $41.7M $14M +$5.54M +65.3% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022
Q3 2019 $36.1M $7.98M -$3.71M -31.7% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020
Q2 2019 $39.9M $13.6M +$10.9M +406% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020
Q1 2019 $29M $6.12M -$5.09M -45.4% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020
Q4 2018 $34.1M $8.48M +$4.89M +136% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021
Q3 2018 $29.2M $11.7M -$7.15M -38% 01 Jul 2018 30 Sep 2018 10-Q 04 Nov 2019
Q2 2018 $36.3M $2.68M +$19.4M 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019
Q1 2018 $16.9M $11.2M -$1.87M -14.3% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q4 2017 $18.7M $3.59M -$16.5M -82.2% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020
Q3 2017 $35.3M $18.8M +$2.17M +13% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018
Q2 2017 $33.1M -$16.8M -$32.5M -207% 01 Apr 2017 30 Jun 2017 10-Q 30 Jul 2018
Q1 2017 $65.6M $13.1M -$2.71M -17.2% 01 Jan 2017 31 Mar 2017 10-Q 27 Apr 2018
Q4 2016 $68.3M $20.1M +$1.14M +5.98% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019
Q3 2016 $67.2M $16.7M -$1.37M -7.59% 01 Jul 2016 30 Sep 2016 10-Q 27 Oct 2017
Q2 2016 $68.5M $15.7M -$1.47M -8.54% 01 Apr 2016 30 Jun 2016 10-Q 31 Jul 2017
Q1 2016 $70M $15.8M +$159K +1.02% 01 Jan 2016 31 Mar 2016 10-Q 28 Apr 2017
Q4 2015 $69.9M $19M -$524K -2.68% 01 Oct 2015 31 Dec 2015 10-K 26 Feb 2018
Q3 2015 $70.4M $18M +$2.68M +17.5% 01 Jul 2015 30 Sep 2015 10-Q 01 Nov 2016
Q2 2015 $67.7M $17.2M +$1.71M +11% 01 Apr 2015 30 Jun 2015 10-Q 29 Jul 2016
Q1 2015 $66M $15.6M +$2.55M +19.5% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016
Q4 2014 $63.4M $19.5M +$4.58M +30.6% 01 Oct 2014 31 Dec 2014 10-K 27 Feb 2017
Q3 2014 $58.9M $15.4M +$7.16M +87.5% 01 Jul 2014 30 Sep 2014 10-Q 30 Oct 2015
Q2 2014 $51.7M $15.5M +$6.2M +66.8% 01 Apr 2014 30 Jun 2014 10-Q 31 Jul 2015
Q1 2014 $45.5M $13.1M -$1.11M -7.8% 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015
Q4 2013 $46.6M $14.9M -$1.73M -10.4% 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016
Q3 2013 $48.3M $8.19M -$5.03M -38.1% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014
Q2 2013 $53.4M $9.28M -$4.33M -31.8% 01 Apr 2013 30 Jun 2013 10-Q 30 Jul 2014
Q1 2013 $57.7M $14.2M +$1.18M +9.04% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014
Q4 2012 $56.5M $16.7M +$145K +0.88% 01 Oct 2012 31 Dec 2012 10-K 27 Feb 2015
Q3 2012 $56.4M $13.2M -$712K -5.11% 01 Jul 2012 30 Sep 2012 10-Q 01 Nov 2013
Q2 2012 $57.1M $13.6M +$800K +6.25% 01 Apr 2012 30 Jun 2012 10-Q 25 Jul 2013
Q1 2012 $56.3M $13M +$1.71M +15.1% 01 Jan 2012 31 Mar 2012 10-Q 26 Apr 2013
Q4 2011 $54.6M $16.5M +$1.86M +12.6% 01 Oct 2011 31 Dec 2011 10-K 27 Feb 2014
Q3 2011 $52.7M $13.9M +$940K +7.23% 01 Jul 2011 30 Sep 2011 10-Q 02 Nov 2012
Q2 2011 $51.8M $12.8M +$797K +6.64% 01 Apr 2011 30 Jun 2011 10-Q 02 Aug 2012
Q1 2011 $51M $11.3M -$1.02M -8.25% 01 Jan 2011 31 Mar 2011 10-Q 30 Apr 2012
Q4 2010 $52M $14.7M 01 Oct 2010 31 Dec 2010 10-K 27 Feb 2013
Q3 2010 $13M 01 Jul 2010 30 Sep 2010 10-Q 04 Nov 2011
Q2 2010 $12M 01 Apr 2010 30 Jun 2010 10-Q 05 Aug 2011
Q1 2010 $12.3M 01 Jan 2010 31 Mar 2010 10-Q 29 Apr 2011

CHEMED CORP Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $97.5M +$19.6M +25.2% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 $77.9M -$2.2M -2.74% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $80.1M -$1.71M -2.09% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $81.8M +$5.24M +6.85% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024
2020 $76.5M +$34.8M +83.6% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023
2019 $41.7M +$7.63M +22.4% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 $34.1M +$15.3M +81.7% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 $18.7M -$49.6M -72.6% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 $68.3M -$1.54M -2.21% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 $69.9M +$6.42M +10.1% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018
2014 $63.4M +$16.8M +36.1% 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017
2013 $46.6M -$9.91M -17.5% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016
2012 $56.5M +$1.94M +3.55% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015
2011 $54.6M +$2.58M +4.96% 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014
2010 $52M 01 Jan 2010 31 Dec 2010 10-K 27 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.